The Sonopet deal is worth $67 million in upfront payments to the company as well as potential future milestone and royalty payments of up to an additional $36 million.
OtisMed will become part of Stryker’s Orthopaedics division but will still be based in Alameda, Calif.
Read Stryker’s release on OtisMed and the Sonopet Ultrasonic Aspirator.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
